Spotlight On... GlaxoSmithKline expands its 'electroceuticals' program; Pulmatrix teams with Capsugel; and more...

GlaxoSmithKline ($GSK), targeting the intersection of medicine and technology, is working with Nuviant Medical, using the company's devices to fuel preclinical research. Nuviant is at work on a device designed to treat chronic disease through neurostimulation, and GSK is licensing the platform to do its own R&D. The move is part of GSK's commitment to what it calls "electroceuticals," a program unveiled in 2013 that includes a $50 million fund to back startups in the field. Release

@FierceBiotech: Seven Bridges raises $45M to fuel drive to be the backbone of large-scale genome projects. More from FierceBiotechIT | Follow @FierceBiotech

@JohnCFierce: Got plenty of cash? Market carnage sets up a Darwinian showdown in biotech. Story | Follow @JohnCFierce

@DamianFierce: there must be at least one person at who also had NBA All-Star tickets and is just FURIOUS. | Follow @DamianFierce

> Capsugel and Pulmatrix ($PULM) have teamed up to develop new inhaled therapies, partnering to develop and manufacture treatments for COPD, cystic fibrosis and idiopathic pulmonary fibrosis. News

> Synergy Pharmaceuticals ($SGYP) signed a deal to apply Bind Therapeutics' ($BIND) drug delivery technology to an early-stage cancer treatment. Item

> Cellceutix ($CTIX) wrapped up a Phase I study for Kevetrin, a treatment for solid tumors, and is now blueprinting a Phase II effort. Release

Medical Device News

@FierceMedDev: ICYMI from FierceDrugDelivery: FDA says drug delivery devices need human factors validation testing. Article | Follow @FierceMedDev

@EmilyWFierce: Pfizer takes a $784M hit with Medicaid pricing settlement. FiercePharma story | Follow @EmilyWFierce

> Theranos sends plan to CMS for solving problems at beleaguered California lab. Report

> Data analysis startup cashes in on precision medicine trend with $45M in tow. Story

> GSK partners with Belgian neurostim startup in bioelectronic medicine research. More

> Stryker bulks up in emergency medicine with $1.3B purchase of Physio-Control. Article

Pharma News

@FiercePharma: Zoetis beats estimates in Q4 but dampens 2016 sales forecast on currency woes. FierceAnimalHealth story | Follow @FiercePharma

@EricPFierce: ICYMI from FiercePharmaManufacturing: Eisai bulks up on bulk drugs for Japan's growing generics market. Doubling capacity in India. Article | Follow @EricPFierce

@CarlyHFierce: ICYMI last week: Novartis takes aim at Remicade market with EU biosim rights from Pfizer. More | Follow @CarlyHFierce

> Merck's cholesterol meds Zetia, Vytorin lose final appeal for bigger CV market. Report

> Express Scripts steps up its Valeant feud with microscopic look at every claim. Story

> Pfizer takes a $784M hit with Medicaid pricing settlement. Article

Animal Health News

> VCA beats on earnings in Q4 with growth in animal hospital and lab businesses. Story

> Startup aims to match ailing pets with clinical trials that could help people, too. More

> Trupanion beats Q4 estimates as vet clinics snap up Express insurance product. Report

> Zoetis beats estimates in Q4 but dampens 2016 sales forecast on currency woes. Article

> Investors applaud Schein's record sales and earnings. Item

Biotech IT News

> Biogen allies with GSK in precompetitive computational biology collaboration. Report

> 10x Genomics strikes deals with Illumina, Agilent and Qiagen. News

> Illumina shares details of semiconductor-based sequencing device. Item

> Seven Bridges raises $45M to fuel drive to be the backbone of large-scale genome projects. Story

> Illumina, Icon land data deals with U.K. mass genome sequencing program. Article

Drug Delivery News

> Early-stage drug delivery implant targeting pancreatic cancer tumors showing promise. Report

> Shape, flexibility of nanoparticles give them an edge against cancer. More

> Amgen deploys West Pharma vials to store its injectable cancer med Imlygic. Item

> Gold nanoparticle clusters and bursts of infrared light eliminate post-surgery tumor cells. Story

> BioCryst stock in dumps after it terminates soft gel arm of its rare disease candidate. Article

Pharma Manufacturing News

> Pfizer recalls children's Advil in Canada; 'clumps' could cause dosing mistakes. More

> Vet drugmaker Chanelle Group putting €70M into Ireland plant. Item

> Perrigo recalling 200M units of antifungus drug over labeling mishap. Report

> Sun to ask for FDA reinspection of troubled Halol plant. Story

> Buffalo, NY-based drug developer says it will build biologics plant, hire 900. Article

Pharma Asia News

> Indonesia clears decks for foreign API manufacturers. Article

> China push to bring biotech talent home is paying off. More

> China healthcare exports need marketing, quality push after acquisitions: L.E.K. Story

> China renews consolidation drive for drug manufacture, wants TCM push. Article

> India's MedGenome pledges $10M for South Asia sequencing effort. Report

Suggested Articles

Almirall and Iktos will use the latter's AI technology to design new compounds that tick multiple drug criteria boxes.

Pfizer’s 2017 spinout company SpringWorks has lost president and founder Lara Sullivan, M.D., who has moved over to Pyxis Oncology as its new chief.

In this week's EuroBiotech Report, Sanofi inks $2.5B Synthorx takeover and posts sutimlimab data, Roche shares bispecific results and more.